Myopia management is a global epidemic with clinical experts around the world working effectively to learn more about fighting the epidemic. Please find these listed resources as trusted educational links for more information

BRIEN HOLDEN VISION INSTITUTE

The Myopia Calculator is a tool that helps eye care practitioners, individuals, patients and parents to apply the research based evidence for various management options and enables the practitioner to demonstrate and discuss ‘risk versus benefit’ for individual cases.

The Myopia Calculator is used daily by thousands of eye care professionals worldwide as they strive to explain myopia progression to their patients. It is the most widely used tool the Brien Holden Vision Institute has developed to date.

Click for the Calculator

MY KIDS VISION

A comprehensive user-friendly website for parents that breaks down the concerns of myopia, myopia progression and consideration of treatment options for your child. Designed by Drs. Kate and Paul Gifford who are global experts in myopia control practising in Australia.

Click for "My Kids Vision" Link

MYOPIA CONTROL TREATMENT SUMMARIES

Myopia Control 2020: Where we are and where are we heading?

Mark Bullimore, O.D., PhD, and Kathryn Richdale, O.D., PhD

Current Status on the Development and Treatment of Myopia

Jeffrey Cooper M.S., O.D., Erica Schulman, O.D., and Nadine Jamal O.D.

An evidence-based update on myopia and interventions to retard its progression

Seo-Wei Leo, MB BS, FRCSEd(Ophth)a,b and Terri L. Young, MD, FAOS, FARVOc,d

SPECTACLE LENS DEFOCUS DESIGN

MIYOSMART Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial

Carly Siu Yin Lam ,1 Wing Chun Tang,1 Dennis Yan-yin Tse, 1 Roger Pak Kin Lee,1 Rachel Ka Man Chun,1 Keigo Hasegawa,2 Hua Qi,2 Takashi Hatanaka,2 Chi Ho To

MIYOSMART Defocus spectacle lens : Detailed brochure on lens design and wear

PERIPHERAL DEFOCUS SOFT CONTACT LENSES

A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control

Chamberlain, Paul BSc (Hons)1*; Peixoto-de-Matos, Sofia C. MSc2; Logan, Nicola S. PhD3; Ngo, Cheryl MBBS, MMed4; Jones, Deborah BSc, FAAO5; Young, Graeme PhD, FAAO

A Randomized Trial of Soft Multifocal Contact Lenses for Myopia Control: Baseline Data and Methods

Jeffrey J. Walline, OD, PhD, FAAO,1 Amber Gaume Giannoni, OD, FAAO,2 Loraine T. Sinnott, PhD,1 Moriah A. Chandler, OD,2 Juan Huang, OD, PhD, FAAO,1 Donald O. Mutti, OD, PhD, FAAO,1 Lisa A. Jones-Jordan, PhD, FAAO,1 David A. Berntsen, OD, PhD, FAAO,2 and for the BLINK Study Group

ORTHOKERATOLOGY

Orthokeratology to control myopia progression: a meta-analysis Sun Y1, Xu F2, Zhang T3, Liu M3, Wang D3, Chen Y3, Liu Q

Overnight Orthokeratology Bullimore, Mark and Johnson, Leah

Low-Dose Atropine

Atropine for the treatment of childhood myopia (ATOM 1) Chua WH1, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, Tan D.

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2 Myopia Control with Atropine 0.01% Eyedrops (ATOM 2)

Audrey Chia, FRANZCO, PhD,1,2 Qing-Shu Lu, PhD,3,4 Donald Tan, FRCS, FRCOphth

Low-Concentration Atropine for Myopia Progression (LAMP) Study A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control

Jason C. Yam, FCOphthHK, FRCS(Edin),1 Yuning Jiang, MMED,1 Shu Min Tang, PhD,1 Antony K.P. Law, MSc,1 Joyce J. Chan, MRCSEd(Ophth),1 Emily Wong, MBChB, MRCS(Edin),1 Simon T. Ko, FCOphthHK, FHKAM(Oph),2 Alvin L. Young, MMedSc(Hons), FRCOphth,1,3 Clement C. Tham, FCOphthHK, FRCOphth,1 Li Jia Chen, MRCSEd(Ophth), PhD,1,3 Chi Pui Pang, DPhil1

Update in myopia and treatment strategy of atropine use in myopia control

Pei-Chang Wu, Meng-Ni Chuang, Jessy Choi, Huan Chen, Grace Wu, Kyoko Ohno-Matsui, Jost B Jonas &Chui Ming Gemmy Cheung